D305-2907 Screening compound: ethyl 4-({1-ethyl-5-[(phenylcarbamoyl)amino]-1H-1,3-benzodiazol-2-yl}methyl)piperazine-1-carboxylate

D305-2907 Screening compound: ethyl 4-({1-ethyl-5-[(phenylcarbamoyl)amino]-1H-1,3-benzodiazol-2-yl}methyl)piperazine-1-carboxylate
D305-2907 Screening compound: ethyl 4-({1-ethyl-5-[(phenylcarbamoyl)amino]-1H-1,3-benzodiazol-2-yl}methyl)piperazine-1-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound D305-2907
ethyl 4-({1-ethyl-5-[(phenylcarbamoyl)amino]-1H-1,3-benzodiazol-2-yl}methyl)piperazine-1-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D305-2907

Molecular Formula

C24H30N6O3 (C24 H30 N6 O3)

Compound Name

ethyl 4-({1-ethyl-5-[(phenylcarbamoyl)amino]-1H-1,3-benzodiazol-2-yl}methyl)piperazine-1-carboxylate

IUPAC name

ethyl 4-({1-ethyl-5-[(phenylcarbamoyl)amino]-1H-13-benzodiazol-2-yl}methyl)piperazine-1-carboxylate

SMILES

CCn1c(ccc(NC(Nc2ccccc2)=O)c2)c2nc1CN(CC1)CCN1C(OCC)=O

InChI

InChI=1S/C24H30N6O3/c1-3-30-21-11-10-19(26-23(31)25-18-8-6-5-7-9-18)16-20(21)27-22(30)17-28-12-14-29(15-13-28)24(32)33-4-2/h5-11,16H,3-4,12-15,17H2,1-2H3,(H2,25,26,31)

InChI Key

KNMAXAMARFXYQJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09222722

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

450.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.929

Distribution Coefficient, logD

3.922

Water Solubility, LogSw

-3.85

Polar Surface Area

69.955

Acid Dissociation Constant (pKa)

13.40

Base Dissociation Constant (pKb)

5.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

D305-2907 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D305-2907 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D305-2907?
Check Price and Availability of D305-2907, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D305-2907 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D305-2907
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D305-2907
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D305-2907 available by request